CACNG5 and Parkinson disease: In the PD mouse model, inhibiting the expression of miR-96 reduces the activation of iNOS by promoting CACNG5 inhibition of MAPK signaling pathway in PD mice, thereby reducing the damage of dopaminergic neurons and restoring the dysfunction of motor system [151].